Fig. 2
From: SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer
Illumina HiSeq mRNA expression of SATB2 (a) and CDX2 (b) in the colon adenocarcinoma dataset in the Cancer Genome Pan Cancer Atlas stratified by microsatellite instability status, BRAF V600E mutation, and KRAS exon 2 or exon 3 mutations
